Aaron G Baugh

8PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 17, 2026
Dihydropyrimidine dehydrogenase modulates immune response to checkpoint inhibition in mismatch repair deficient/microsatellite instability-high colorectal cancer.

|Aug 11, 2026
Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

|Apr 03, 2026
A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells.

Aaron G Baugh, Yingtong Liu, Edgar Gonzalez

|Jul 15, 2025
Cancer systems immunology reveals myeloid-T cell interactions and B cell activation mediate response to checkpoint inhibition in metastatic breast cancer.

Edgar Gonzalez, Jesse Kreger, Yingtong Liu

|Jun 30, 2025
Sequencing analysis reveals evidence of immune activation in advanced HER2 negative breast cancer responders treated with entinostat + nivolumab + ipilimumab.

Evanthia Roussos Torres, Ludmila Danilova, Jospeh Tandurella

|Jul 09, 2024
Targeting MDSC-HTR2B to Improve Immune Checkpoint Inhibitors in Breast to Brain Metastasis.

Mukund Iyer, Diganta Das, Aaron G Baugh

Pageof 2

Frequent Collaborators

6 joint publications

Evanthia T Roussos Torres

5 joint publications

Jesse Kreger

4 joint publications

Adam MacLean

3 joint publications

Roisin M Connolly